Gilead Sciences is expanding its cell therapy pipeline and technological capabilities through the $7.8 billion acquisition of Arcellx, its partner in the development of a multiple myeloma treatment ...

Conroe City Council offered no support Thursday for a variance that would permit a 160-foot-tall cell tower disguised as a pine tree to be constructed in a residential area. Following a public hearing ...

Students who repeatedly use their phones at school could have their devices confiscated for up to a semester under Houston ISD's updated cell phone policy. Under a new state law, school districts ...

The DOJ on Monday released shocking footage that appeared to be a recreation of Jeffrey Epstein’s suicide in his Manhattan jail cell — and it briefly set the internet on fire until it was revealed to ...

The chimeric antigen receptor (CAR) T cell therapy anitocabtagene autoleucel (anito-cel) continued to show strong results in treating relapsed/refractory multiple myeloma, according to new trial data ...

The 2025 meeting of the American Society of Hematology features some of the newest developments in blood cancers and rare diseases. The 2025 annual meeting of the American Society of Hematology (2025) ...

Emerging immunotherapy treatments for multiple myeloma target B-cell maturation antigen (BCMA), a protein found on the surface of cancer cells. Multiple myeloma is a blood cancer that develops when ...

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalized treatment can slow or even ...

I’m addicted to my phone. Wow, it feels good to say it! This uncomfortable truth sharpened recently when a friend shared her pet peeve about cell phones on the table when dining out with companions.

HOUSTON--(BUSINESS WIRE)--Leading U.S. stem cell banking and cellular therapeutic manufacturer Hope Biosciences announces the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine ...

A team of scientists led by the Institute for Glial Sciences (IGS) at Case Western Reserve University's School of Medicine has discovered a built-in "brake" that controls when key brain cells mature.